Literature DB >> 1700450

Effects of X irradiation on angiogenesis.

S D Prionas1, J Kowalski, L F Fajardo, I Kaplan, H H Kwan, A C Allison.   

Abstract

We have evaluated the effect of X irradiation on the mesenchymal tissue growth (blood capillaries and stromal cells) in an angiogenesis system in the mouse. This was accomplished by implanting a polyvinyl alcohol sponge disc in the subcutis of the thorax, and quantifying the extent of growth reduction of capillaries and stromal cells following graded doses of X rays. The sponge disc contained a centrally located pellet impregnated with 20 micrograms of epidermal growth factor and coated with a thin film of slow-releasing compound. Total growth of vessels and fibroblasts was determined by morphometric analysis of histologic sections. The incorporation of [3H]TdR was measured during a 24-h period. A dose-response relationship was observed when X irradiation was given on Day 11 after implantation, with the disc removed on Day 20. A single dose of 15 Gy reduced both the rate of incorporation of [3H]TdR and the total growth area. These and previous observations point to endothelial cells as important targets of ionizing radiation in the stroma, especially during the period of active proliferation of these cells, induced by growth factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700450

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  10 in total

1.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

Review 2.  Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.

Authors:  Brown J Martin
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

3.  Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model.

Authors:  F Griscelli; H Li; C Cheong; P Opolon; A Bennaceur-Griscelli; G Vassal; J Soria; C Soria; H Lu; M Perricaudet; P Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 4.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

5.  Dual role of tumor necrosis factor-alpha in angiogenesis.

Authors:  L F Fajardo; H H Kwan; J Kowalski; S D Prionas; A C Allison
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

6.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 8.  TRAM flap breast reconstruction after radiation treatment.

Authors:  J K Williams; J Bostwick; J T Bried; G Mackay; J Landry; J Benton
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

9.  In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity.

Authors:  O Hatjikondi; P Ravazoula; D Kardamakis; J Dimopoulos; S Papaioannou
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.

Authors:  M Johansson; A T Bergenheim; A Widmark; R Henriksson
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.